Phillip Febbo

Track

Insider profile

Currently holds positions in Varian Medical Systems Inc and Illumina Inc

Positions

Position Company Period
Independent Director Varian Medical Systems Inc Aug. 16, 2019 -
Senior Vice President, Chief Medical Officer Illumina Inc March 26, 2018 -
Chief Medical Officer Varian Medical Systems Inc Jan. 1, 2018 - Aug. 16, 2019
Chief Medical Officer Illumina Inc None -
Chief Medical Officer Genomic Health Inc Aug. 1, 2013 - Jan. 1, 2018
Phillip Febbo's trades of Veracyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
379.43
Quantity 82,422 +29.3%
Value US$37,991
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
11.64
Quantity 43,082 +49.9%
Value US$2,741,479
US Veracyte Inc (VCYT)
Transaction date
Proposed sale
Price
129.33
Quantity 93,277
Value US$3,363,773
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
36.16
Quantity 13,425 -10.3%
Value US$485,429
US Veracyte Inc (VCYT)
Transaction date
Proposed sale
Price
36.59
Quantity 13,425
Value US$491,221
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
36.02
Quantity 8,349 -8.3%
Value US$300,709
US Veracyte Inc (VCYT)
Transaction date
Proposed sale
Price
36.00
Quantity 8,349
Value US$300,564
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
33.95
Quantity 3,570 -4.1%
Value US$121,205
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
32.86
Quantity 4,467 -4.9%
Value US$146,808
US Veracyte Inc (VCYT)
Transaction date
Proposed sale
Price
33.56
Quantity 8,037
Value US$269,722
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
44.09
Quantity 3,934 -4.6%
Value US$173,447
US Veracyte Inc (VCYT)
Transaction date
Proposed sale
Price
44.09
Quantity 1,311
Value US$57,802
US Veracyte Inc (VCYT)
Transaction date
Proposed sale
Price
43.66
Quantity 2,623
Value US$114,520
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
360.01
Quantity 1,988 -25.6%
Value US$715,700
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
406.83
Quantity 1,000 -24.9%
Value US$406,830
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
449.02
Quantity 290 -6.1%
Value US$130,216
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
447.65
Quantity 400 -7.8%
Value US$179,060
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
446.17
Quantity 310 -5.7%
Value US$138,313
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
310.10
Quantity 155 -6.7%
Value US$48,066
US Illumina Inc (ILMN)
Transaction date
Planned sale
Price
300.00
Quantity 173 -6.5%
Value US$51,900
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-04
US Veracyte Inc (VCYT)
PlS Planned sale
82,422 +29.3%
379.43
US$37,991 		82,422 +29.3% 379.43 US$37,991
2026-09-04 2026-09-04
US Veracyte Inc (VCYT)
PlS Planned sale
43,082 +49.9%
11.64
US$2,741,479 		43,082 +49.9% 11.64 US$2,741,479
2026-09-04 2026-09-04
US Veracyte Inc (VCYT)
PrS Proposed sale
93,277
129.33
US$3,363,773 		93,277 129.33 US$3,363,773
2026-03-04 2026-03-02
US Veracyte Inc (VCYT)
PlS Planned sale
13,425 -10.3%
36.16
US$485,429 		13,425 -10.3% 36.16 US$485,429
2026-03-02 2026-03-02
US Veracyte Inc (VCYT)
PrS Proposed sale
13,425
36.59
US$491,221 		13,425 36.59 US$491,221
2025-10-07 2025-10-06
US Veracyte Inc (VCYT)
PlS Planned sale
8,349 -8.3%
36.02
US$300,709 		8,349 -8.3% 36.02 US$300,709
2025-10-06 2025-10-06
US Veracyte Inc (VCYT)
PrS Proposed sale
8,349
36.00
US$300,564 		8,349 36.00 US$300,564
2025-03-06 2025-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
3,570 -4.1%
33.95
US$121,205 		3,570 -4.1% 33.95 US$121,205
2025-03-06 2025-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
4,467 -4.9%
32.86
US$146,808 		4,467 -4.9% 32.86 US$146,808
2025-03-04 2025-03-04
US Veracyte Inc (VCYT)
PrS Proposed sale
8,037
33.56
US$269,722 		8,037 33.56 US$269,722
2024-12-06 2024-12-04
US Veracyte Inc (VCYT)
PlS Planned sale
3,934 -4.6%
44.09
US$173,447 		3,934 -4.6% 44.09 US$173,447
2024-12-05 2024-12-04
US Veracyte Inc (VCYT)
PrS Proposed sale
1,311
44.09
US$57,802 		1,311 44.09 US$57,802
2024-12-04 2024-12-04
US Veracyte Inc (VCYT)
PrS Proposed sale
2,623
43.66
US$114,520 		2,623 43.66 US$114,520
2022-04-07 2022-04-06
US Illumina Inc (ILMN)
PlS Planned sale
1,988 -25.6%
360.01
US$715,700 		1,988 -25.6% 360.01 US$715,700
2021-11-09 2021-11-08
US Illumina Inc (ILMN)
PlS Planned sale
1,000 -24.9%
406.83
US$406,830 		1,000 -24.9% 406.83 US$406,830
2021-06-14 2021-06-11
US Illumina Inc (ILMN)
PlS Planned sale
290 -6.1%
449.02
US$130,216 		290 -6.1% 449.02 US$130,216
2021-06-14 2021-06-11
US Illumina Inc (ILMN)
PlS Planned sale
400 -7.8%
447.65
US$179,060 		400 -7.8% 447.65 US$179,060
2021-06-14 2021-06-11
US Illumina Inc (ILMN)
PlS Planned sale
310 -5.7%
446.17
US$138,313 		310 -5.7% 446.17 US$138,313
2020-11-09 2020-11-06
US Illumina Inc (ILMN)
PlS Planned sale
155 -6.7%
310.10
US$48,066 		155 -6.7% 310.10 US$48,066
2020-04-20 2020-04-16
US Illumina Inc (ILMN)
PlS Planned sale
173 -6.5%
300.00
US$51,900 		173 -6.5% 300.00 US$51,900